Substitution of only two residues of human Hsp90α causes impeded dimerization of Hsp90β

被引:0
作者
Takeshi Kobayakawa
Shin-ichi Yamada
Akio Mizuno
Takayuki K. Nemoto
机构
[1] Nagasaki University Graduate School of Biomedical Sciences,Department of Oral Molecular Biology, Course of Medical and Dental Sciences
[2] Nagasaki University Graduate School of Biomedical Sciences,Department of Oral and Maxillofacial Surgery, Course of Medical and Dental Sciences
来源
Cell Stress and Chaperones | 2008年 / 13卷
关键词
Hsp90; Dimerization; Amino acid substitution; Molecular chaperone;
D O I
暂无
中图分类号
学科分类号
摘要
Two isoforms of the 90-kDa heat-shock protein (Hsp90), i.e., Hsp90α and Hsp90β, are expressed in the cytosol of mammalian cells. Although Hsp90 predominantly exists as a dimer, the dimer-forming potential of the β isoform of human and mouse Hsp90 is less than that of the α isoform. The 16 amino acid substitutions located in the 561–685 amino acid region of the C-terminal dimerization domain should be responsible for this impeded dimerization of Hsp90β (Nemoto T, Ohara-Nemoto Y, Ota M, Takagi T, Yokoyama K. Eur J Biochem 233: 1–8, 1995). The present study was performed to define the amino acid substitutions that cause the impeded dimerization of Hsp90β. Bacterial two-hybrid analysis revealed that among the 16 amino acids, the conversion from Ala558 of Hsp90β to Thr566 of Hsp90α and that from Met621 of Hsp90β to Ala629 of Hsp90α most efficiently reversed the dimeric interaction, and that the inverse changes from those of Hsp90α to Hsp90β primarily explained the impeded dimerization of Hsp90β We conclude that taken together, the conversion of Thr566 and Ala629 of Hsp90α to Ala558 and Met621 is primarily responsible for impeded dimerization of Hsp90β.
引用
收藏
页码:97 / 104
页数:7
相关论文
共 50 条
  • [21] Hsp90 at the crossroads of genetics and epigenetics
    Keith SK Wong
    Walid A Houry
    Cell Research, 2006, 16 : 742 - 749
  • [22] Identification of two hsp90 genes in carp
    Hermesz, E
    Abrahám, M
    Nemcsók, J
    COMPARATIVE BIOCHEMISTRY AND PHYSIOLOGY C-TOXICOLOGY & PHARMACOLOGY, 2001, 129 (04): : 397 - 407
  • [23] Targeting Hsp90 in urothelial carcinoma
    Chehab, Mahmoud
    Caza, Tiffany
    Skotnicki, Kamil
    Landas, Steve
    Bratslavsky, Gennady
    Mollapour, Mehdi
    Bourboulia, Dimitra
    ONCOTARGET, 2015, 6 (11) : 8454 - 8473
  • [24] Targeting Hsp90 for the treatment of cancer
    Drysdale, Martin J.
    Brough, Paul A.
    Massey, Andrew
    Jensen, Michael Rugaard
    Schoepfer, Joseph
    CURRENT OPINION IN DRUG DISCOVERY & DEVELOPMENT, 2006, 9 (04) : 483 - 495
  • [25] Traditional and Novel Mechanisms of Heat Shock Protein 90 (HSP90) Inhibition in Cancer Chemotherapy Including HSP90 Cleavage
    Park, Sangkyu
    Park, Jeong-A
    Jeon, Jae-Hyung
    Lee, Younghee
    BIOMOLECULES & THERAPEUTICS, 2019, 27 (05) : 423 - 434
  • [26] Hsp90: A Drug Target?
    Jeffrey M. Holzbeierlein
    Andrew Windsperger
    George Vielhauer
    Current Oncology Reports, 2010, 12 : 95 - 101
  • [27] Hsp90: A Drug Target?
    Holzbeierlein, Jeffrey M.
    Windsperger, Andrew
    Vielhauer, George
    CURRENT ONCOLOGY REPORTS, 2010, 12 (02) : 95 - 101
  • [28] Inhibitors of HSP90 in melanoma
    Mielczarek-Lewandowska, Aleksandra
    Hartman, Mariusz L.
    Czyz, Malgorzata
    APOPTOSIS, 2020, 25 (1-2) : 12 - 28
  • [29] Hsp90 at the crossroads of genetics and epigenetics
    KeithSKWong
    WalidAHoury
    CellResearch, 2006, (09) : 10 - 10
  • [30] Hsp90, the concertmaster: tuning transcription
    Khurana, Nidhi
    Bhattacharyya, Sunanda
    FRONTIERS IN ONCOLOGY, 2015, 5